ArticleMolecular medicine reports2025

KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF‑β mediated epithelial‑mesenchymal transition.

Yaoyu Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.